CLYM 424B5: Secondary offering
Climb Bio, Inc.
Filed with the SEC on · accession 0001193125-26-269510
CLYM filed a 424B5 (prospectus (offering)) with the SEC on Jun 12, 2026. The final terms of an offering of shares or bonds. The stock moved +4.9% by the first close after the filing.
Summary of the filing
Climb Bio, Inc. entered into an Open Market Sale Agreement with Jefferies LLC to sell up to $100,000,000 of its common stock in at-the-market offerings.
Key details
How CLYM stock reacted
Close before
$10.91
Jun 11, 2026
First close after
+4.86%
$11.44
5 trading days
+4.95%
$11.45
Since filing
-18.70%
$8.87
✦ Ask GOAX AI about this filing — what it means for CLYM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CLYM?
Click hereFrequently asked questions
What did CLYM file with the SEC on Jun 12, 2026?
CLYM filed a 424B5 (Secondary offering). Climb Bio, Inc. entered into an Open Market Sale Agreement with Jefferies LLC to sell up to $100,000,000 of its common stock in at-the-market offerings.
What does a secondary offering mean for CLYM stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did CLYM stock react to this filing?
CLYM closed at $10.91 before the filing and $11.44 on Jun 12, 2026 (+4.86%). Five trading days later: $11.45 (+4.95%).
Other CLYM SEC filings
Get alerts when CLYM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days